Systemic Sclerosis (Scleroderma): Specific Autoantigen Genes Are Selectively Overexpressed in Scleroderma Fibroblasts

• Published in: The Journal of immunology (1950) 2001-12, Vol.167 (12), p.7126-7133
• Main Authors: Zhou, Xiaodong, Tan, Filemon K, Xiong, Momiao, Milewicz, Dianna M, Feghali, Carol A, Fritzler, Marvin J, Reveille, John D, Arnett, Frank C
• Format: Article
• Language: English
• Subjects: Autoantigens - genetics; Autoantigens - metabolism; Autoimmune Diseases - genetics; Autoimmune Diseases - immunology; Cells, Cultured; Dermis - cytology; DNA microarrays; Fibroblasts - metabolism; Gene Expression Profiling; Humans; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - biosynthesis; Scleroderma, Systemic - genetics; Scleroderma, Systemic - immunology; systemic sclerosis; Transcriptional Activation
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.167.12.7126

The pathogenesis of systemic sclerosis (SSc) involves complex interactions between activated fibroblasts eventually leading to fibrosis, and impaired immune tolerance characterized by a variety of circulating SSc-specific autoantibodies. The expression of autoantigens in fibroblasts, a key target tissue in SSc, may play an important role in this process. To obtain a global view of this process, we examined gene expression profiles of SSc dermal fibroblasts using cDNA microarrays. The results show that dermal fibroblasts from SSc patients obtained from either affected or unaffected skin displayed a characteristic pattern of increased SSc autoantigen gene expression compared with that from normal controls. In particular, fibrillarin (p = 0.028), centromeric protein B (p = 0.01), centromeric autoantigen P27 (p = 0.042), and RNA polymerase II (220 kDa; p = 0.02) were significantly overexpressed in SSc fibroblasts. Quantitative RT-PCR confirmed overexpression of these autoantigens and also revealed increased levels of DNA topoisomerase I transcripts in SSc fibroblasts compared with normal control fibroblasts (p = 0.0318). The polymyositis/scleroderma autoantigen gene was overexpressed in some SSc patients (p = 0.09). To examine the specificity of these overexpressed autoantigen genes for SSc and its tissue specificity for fibroblasts, cDNA microarrays of dermal fibroblasts from patients with eosinophilic fasciitis and scleromyxedema were studied as well as PBMC and muscle biopsies from SSc patients. None of these tissues showed significant alterations in gene expression of SSc-specific autoantigens. Therefore, SSc-associated autoantigen genes are selectively overexpressed in SSc dermal fibroblasts, a major tissue involved in disease pathogenesis.